Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-11-24 Other | 2020-11-27 4:06 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | SAXENA PARAG Chief Executive Officer 10% Owner | 255,094 | $0 | 2,875,000 (Indirect) | View |
| 2020-11-24 Other | 2020-11-27 4:05 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | PAPADOPOULOS STELIOS Director 10% Owner | 255,094 | $0 | 2,875,000 (Indirect) | View |
| 2020-11-24 Other | 2020-11-27 4:05 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | Eucrates LLC 10% Owner | 255,094 | $0 | 2,875,000 (Direct) | View |
Ownership | 2020-10-23 1:24 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | SAXENA PARAG Chief Executive Officer 10% Owner | 0 | $0 | 2,875,000 (Indirect) | View |
Ownership | 2020-10-23 1:23 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | PAPADOPOULOS STELIOS Director 10% Owner | 0 | $0 | 2,875,000 (Indirect) | View |
Ownership | 2020-10-23 1:21 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | Eucrates LLC 10% Owner | 0 | $0 | 2,875,000 (Direct) | View |